Some trials are focusing on drugs that target the immune system, which is affected by different pathways to long covid.

A new study from the Kennedy Krieger Institute is calling attention to an emerging mental health crisis among children with ...

On May 20, U.S. Food and Drug Administration ( FDA) officials announced that Covid-19 vaccines will no longer be available to everyone. Instead, annual boosters will be limited to people ages 65 and ...

A new study from Kennedy Krieger Institute is calling attention to an emerging mental health crisis among children with long COVID. Researchers found that nearly 40% of pediatric patients with long ...

For groups younger than 65 or without specific chronic conditions, postmarketing trials will be needed to open access.

The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit ...

Researchers looked at biomarkers in study participants and found that those complaining of brain fog had higher levels of an ...

In a recent study, a research team from the Medical University of Vienna has gained new insights into post-COVID syndrome ...

Adults who later developed long COVID had lower cardiorespiratory fitness (CRF) before infection than those who did not.

As public health systems strain and families like Jennifer’s wait for solutions, scientists at Johns Hopkins are working ...

University of Virginia researchers uncover immune system changes linked to lung damage in Long COVID patients, offering hope for personalized treatments to address lingering respiratory complications.

Long COVID remains a public health concern, with the highest disease risk observed in older adults, women, and those with preexisting conditions or severe acute illness.